首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Pharmacokinetics of Enrofloxacin and Its Metabolite Ciprofloxacin after Intramuscular Administration of Enrofloxacin in Goats
Authors:Rao  GS  Ramesh  S  Ahmad  AH  Tripathi  HC  Sharma  LD  Malik  JK
Institution:(1) Division of Pharmacology and Toxicology, Indian Veterinary Research Institute, Izatnagar, 243 122 (U.P.), India;(2) Department of Pharmacology and Toxicology, College of Veterinary Sciences, GBPUA&T, Pantnagar, 263 145 (U.P.), India
Abstract:The pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin were investigated in goats after a single intramuscular administration of enrofloxacin at 2.5 mg/kg body weight. The plasma concentrations of enrofloxacin and ciprofloxacin were determined simultaneously by a HPLC method. The peak concentrations (C max) of enrofloxacin (1.13 mgrg/ml) and ciprofloxacin (0.24 mgrg/ml) were observed at 0.8 and 1.2 h, respectively. The elimination half-life (t 1/2beta), volume of distribution (V d(area)), total body clearance (ClB) and mean residence time (MRT) of enrofloxacin were 0.74 h, 1.42 L/kg, 1329 ml/h per kg and 1.54 h, respectively. The t 1/2beta, area under the plasma concentration–time curve (AUC) and the MRT of ciprofloxacin were 1.38 h, 0.74 mgrg h/ml and 2.73 h, respectively. The metabolic conversion of enrofloxacin to ciprofloxacin was appreciable (36%) and the sum of the plasma concentrations of enrofloxacin and ciprofloxacin was maintained at or above 0.1 mgrg/ml for up to 4 h. Enrofloxacin appears to be useful for the treatment of goat diseases associated with pathogens sensitive to this drug.
Keywords:ciprofloxacin  dosage  enrofloxacin  goats  pharmacokinetics  plasma concentrations
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号